Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Mylan Insulin Glargine Study

ClinicalTrials.gov ID: NCT03376789

Public ClinicalTrials.gov record NCT03376789. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 10:14 AM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-center, Double-Blind, Parallel-Group Clinical Study Comparing the Efficacy and Safety of MYL-1501D Produced by Two Manufacturing Processes in Type 1 Diabetes Mellitus Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The aim of this study is to demonstrate similar efficacy and safety between MYL-1501D products produced from two manufacturing processes (Process V and Process VI) in combination with insulin lispro in patients with type 1 diabetes mellitus (T1DM).

Study identification

NCT ID
NCT03376789
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Mylan Inc.
Industry
Enrollment
219 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 29, 2017 (Actual)
Primary completion
Sep 25, 2018 (Actual)
Completion
Jan 10, 2019 (Actual)
Last update posted
Mar 3, 2022

2017 – 2019

United States locations

U.S. sites
38
U.S. states
8
U.S. cities
36
Facility City State ZIP Site status
Mylan Investigator Site Fresno California 93720 —
Mylan Investigator Site Greenbrae California 94904 —
Mylan Investigator Site Huntington Beach California 92648 —
Mylan Investigator Site La Mesa California 91942 —
Mylan Investigator Site Los Gatos California 95032 —
Mylan Investigator Site Mission Hills California 91345 —
Mylan Investigator Site Montclair California 91763 —
Mylan Investigator Site Northridge California 91324 —
Mylan Investigator Site Oakland California 94607 —
Mylan Investigator Site Santa Monica California 90404 —
Mylan Investigator Site Tarzana California 91356 —
Mylan Investigator Site Tustin California 92780 —
Mylan Investigator Site Walnut Creek California 94598 —
Mylan Investigator Site Denver Colorado 80246 —
Mylan Investigator Site Bradenton Florida 34201 —
Mylan Investigator Site Fort Lauderdale Florida 33312 —
Mylan Investigator Site Fort Myers Florida 33912 —
Mylan Investigator Site Hialeah Florida 33012 —
Mylan Investigator Site Maitland Florida 32751 —
Mylan Investigator Site Miami Florida 33126 —
Mylan Investigator Site Miami Florida 33156 —
Mylan Investigator Site Miami Florida 33175 —
Mylan Investigator Site New Port Richey Florida 34652 —
Mylan Investigator Site Palm Harbor Florida 34684 —
Mylan Investigator Site Spring Hill Florida 34609 —
Mylan Investigator Site St. Petersburg Florida 33709 —
Mylan Investigator Site Tampa Florida 33634 —
Mylan Investigator Site West Palm Beach Florida 33401 —
Mylan Investigator Site Atlanta Georgia 30318 —
Mylan Investigator Site Columbus Georgia 31904 —
Mylan Investigator Site Lawrenceville Georgia 30045 —
Mylan Investigator Site Roswell Georgia 30076 —
Mylan Investigator Site Idaho Falls Idaho 83404 —
Mylan Investigator Site Meridian Idaho 83642 —
Mylan Investigator Site Springfield Illinois 62701 —
Mylan Investigator Site Council Bluffs Iowa 51501 —
Mylan Investigator Site Austin Texas 78731 —
Mylan Investigator Site Dallas Texas 75231 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03376789, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 3, 2022 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03376789 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →